The former reflects Hb reduction to a level associated with rising risk of mortality [6], and the latter possible substantial intravascular haemolysis leading to an increased risk of high cell-free Hb and acute renal failure [57]. The gene discussed is GSTM1; the disease is acute kidney injury.